Cryptic peptides for use in inducing immunologic tolerance

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/00 (2006.01) A61K 39/35 (2006.01)

Patent

CA 2164326

Methods of inducing immunologic tolerance in a subject, such as human, by administering a tolerizing amount of a composition comprising a cryptic peptide derived from tbe antigen and a pharmaceutically carrier are described. Compositions which include a cryptic peptide derived from a protein antigen, such as an allergen or autoantigen, can be administered to induce tolerance in a naive or pre-sensitized individual. Preferably, the composition is administered orally.

On décrit des procédés qui permettent d'induire une tolérance immunologique chez un sujet tel que l'homme, grâce à l'administration d'une quantité, favorisant cette tolérance, d'une composition comprenant un peptide caché dérivé de l'antigène et un vecteur pharmaceutiquement acceptable. On peut administrer des compositions qui comportent un peptide caché dérivé d'un antigène protéique tel qu'un allergène ou un autoantigène, afin d'induire une tolérance chez un individu naïf ou présensibilisé. Cette composition s'administre de préférence par la voie orale.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cryptic peptides for use in inducing immunologic tolerance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cryptic peptides for use in inducing immunologic tolerance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cryptic peptides for use in inducing immunologic tolerance will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442696

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.